LB PHARMACEUTICALS INC (LBRX)
↓ Download CSVKey ratios (FY2025)
-8.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Income | -$25.20M | -$63.10M | — |
| EPS (Diluted) | $-3.13 | $-176.15 | — |
| Total Assets | $312.93M | $33.53M | — |
| Total Liabilities | $11.62M | $13.83M | — |
| Shareholders' Equity | $301.31M | -$94.55M | -$34.47M |
| Cash & Equivalents | $250.17M | $22.98M | — |
| Operating Cash Flow | -$35.21M | -$53.05M | — |
| Capital Expenditures | $52.0K | $769.0K | — |
| Shares Outstanding | 25.30M | 251.7K | — |